Agfalva, Hungary

József Gungl

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Sanochemia Pharmazeutika Ag. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: József Gungl. Retrieved from https://idiyas.com/inventor/jozsef-gungl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 90.0


 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Sopron, HU (2013 - 2017)
  • Ágfalva, HU (2017)
  • Agfalva, HU (2017 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jozsef Gungl

Introduction

Jozsef Gungl, an accomplished inventor hailing from Agfalva, Hungary, has made significant strides in the field of pharmaceuticals and medical technologies. With a total of five patents to his name, Gungl is recognized for his pioneering work in photodynamic therapy and liquid pharmaceutical preparations, contributing to advancements in treating various tumors and improving pharmaceutical formulations.

Latest Patents

Two of Gungl's latest patents showcase his commitment to innovation in the medical field. The first patent addresses photodynamic therapy, specifically focusing on methods for treating tumors such as bladder tumors. This method involves using a photosensitizing agent derived from a complex or a compound of hypericin combined with a polymeric complexing agent. The alkali salts of hypericin employed in this treatment are sodium or potassium salts, alongside complexing agents like polyethylene glycol or poly-N-vinyl amide.

The second patent outlines a method for producing a liquid pharmaceutical preparation that utilizes a complex of DOTA and gadolinium. The process involves multiple steps, including the production of an aqueous solution containing DOTA, gadolinium, and a base such as L-lysine or meglumine, followed by complexation at elevated temperatures and pH adjustments to achieve the desired pharmaceutical formulation.

Career Highlights

Throughout his career, Jozsef Gungl has worked with notable companies such as Sanochemia Pharmazeutika, where he has collaborated on key projects focused on pharmaceutical advancements. His contributions have been integral to the development of innovative medical solutions that significantly impact patient care.

Collaborations

In his journey as an inventor, Gungl has collaborated with esteemed colleagues like Stefan Welzig and Klaus Gerdes. Their combined expertise and dedication have fostered an environment of creativity and innovation, enabling the development of groundbreaking therapeutic solutions.

Conclusion

Jozsef Gungl's work exemplifies the essence of innovation in the pharmaceutical industry. With his impressive portfolio of patents and collaborations, he continues to contribute to medical science, particularly in the areas of photodynamic therapy and liquid pharmaceutical preparations. His inventions not only enhance the effectiveness of treatments but also pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…